sensus Statement on Optimal Implantable Cardioverter-Defibrillator Programming and Testing
暂无分享,去创建一个
Jagmeet P. Singh | J. Healey | C. Morillo | A. Russo | R. Berger | S. Viskin | S. Dubner | J. Daubert | K. Kuck | B. Wilkoff | D. Haines | A. Proclemer | N. Estes | K. Okumura | S. Al‐Khatib | M. Stiles | L. Aguinaga | G. Fenelon | M. Gasparini | C. Swerdlow | Chun-Chieh Wang | W. Teo | Fermin C. García | M. Martinelli | W. Uribe | Shu Zhang | R. Keegan | Jodie L. Hurtwitz | Luis G. Molina | Kolb | L. Molina | M. McGuire | Christof | J. Almendral | Laurent | Fauchier | Alejandro | Cuesta | A. Kenneth | Ellenbogen | Germanas | Marinskis
[1] B. Zrenner,et al. ICD Shock, Not Ventricular Fibrillation, Causes Elevation of High Sensitive Troponin T after Defibrillation Threshold Testing—The Prospective, Randomized, Multicentre TropShock-Trial , 2015, PloS one.
[2] Jeffrey L. Anderson. Evolution of the ACC/AHA Clinical Practice Guidelines in Perspective: Guiding the Guidelines. , 2015, Journal of the American College of Cardiology.
[3] J. Svendsen,et al. Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial , 2015, European heart journal.
[4] A. Auricchio,et al. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results. , 2015, Heart rhythm.
[5] J. Pogue,et al. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE) , 2015, The Lancet.
[6] D. Corrado,et al. Multicentre comparison Of shock efficacy using single-vs. Dual-coil lead systems and Anodal vs. cathodaL polarITY defibrillation in patients undergoing transvenous cardioverter-defibrillator implantation. The MODALITY study , 2015, Journal of Interventional Cardiac Electrophysiology.
[7] Paul J. Wang,et al. The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling. , 2015, European heart journal.
[8] D. Babuty,et al. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study. , 2014, JACC. Heart failure.
[9] Shu Zhang,et al. Reduction of unnecessary right ventricular pacing by managed ventricular pacing and search AV+ algorithms in pacemaker patients: 12-month follow-up results of a randomized study. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[10] A. Moss,et al. Mortality Reduction in Relation to Implantable Cardioverter Defibrillator Programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) , 2014, Circulation. Arrhythmia and electrophysiology.
[11] M. Gold,et al. Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator. , 2014, Heart rhythm.
[12] Angel Arenal,et al. Efficacy of Long Detection Interval Implantable Cardioverter-Defibrillator Settings in Secondary Prevention Population: Data From the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) Trial , 2014, Circulation.
[13] D. Lacroix,et al. Decreased Delivery of Inappropriate Shocks Achieved by Remote Monitoring of ICD: A Substudy of the ECOST Trial , 2014, Journal of cardiovascular electrophysiology.
[14] B. Wilkoff,et al. The Epidemic of Inadequate Biventricular Pacing in Patients With Persistent or Permanent Atrial Fibrillation and Its Association With Mortality , 2014, Circulation. Arrhythmia and electrophysiology.
[15] R. Quaglione,et al. Managed ventricular pacing compared with conventional dual-chamber pacing for elective replacement in chronically paced patients: results of the Prefer for Elective Replacement Managed Ventricular Pacing randomized study. , 2014, Heart rhythm.
[16] S. Rosenheck,et al. Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: data from the Israeli ICD Registry. , 2014, Heart rhythm.
[17] G. Boriani,et al. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial , 2014, European heart journal.
[18] J. Healey,et al. Is Defibrillation Testing Necessary for Implantable Transvenous Defibrillators?: Defibrillation Testing Should Not Be Routinely Performed at the Time of Implantable Cardioverter Defibrillator Implantation , 2014, Circulation. Arrhythmia and electrophysiology.
[19] Á. Cequier,et al. The Benefit of a Second Burst Antitachycardia Sequence for Fast Ventricular Tachycardia in Patients with Implantable Cardioverter Defibrillators , 2014, Pacing and clinical electrophysiology : PACE.
[20] A. Russo,et al. OUTCOME FOLLOWING ICD IMPLANTATION WITH VERSUS WITHOUT DEFIBRILLATION TESTING: PRELIMINARY RESULTS OF THE PROSPECTIVE RANDOMIZED TEST-NO TEST (TNT) PILOT STUDY , 2014 .
[21] Xu Wang,et al. Are dual-chamber implantable cardioverter-defibrillators really better than single-chamber ones? A systematic review and meta-analysis , 2014, Journal of Interventional Cardiac Electrophysiology.
[22] D. Exner,et al. Impact of Programming Strategies Aimed at Reducing Nonessential Implantable Cardioverter Defibrillator Therapies on Mortality: A Systematic Review and Meta-Analysis , 2014, Circulation. Arrhythmia and electrophysiology.
[23] A. Maruotti,et al. Cardiovascular mortality and chronotropic incompetence in systolic heart failure: the importance of a reappraisal of current cut‐off criteria , 2014, European journal of heart failure.
[24] S. Solomon,et al. Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT. , 2014, European heart journal.
[25] Y. Nabutovsky,et al. Programming Implantable Cardioverter‐Defibrillators in Patients with Primary Prevention Indication to Prolong Time to First Shock: Results from the PROVIDE Study , 2014, Journal of cardiovascular electrophysiology.
[26] J. Curtis,et al. Patient, Physician, and Procedural Factors Influencing the Use of Defibrillation Testing during Initial Implantable Cardioverter Defibrillator Insertion: Findings from the NCDR® , 2013, Pacing and clinical electrophysiology : PACE.
[27] K. Ellenbogen,et al. Performance of Lead Integrity Alert to Assist in the Clinical Diagnosis of Implantable Cardioverter Defibrillator Lead Failures: Analysis of Different Implantable Cardioverter Defibrillator Leads , 2013, Circulation. Arrhythmia and electrophysiology.
[28] K. Ellenbogen,et al. Implantable cardioverter-defibrillator leads: design, diagnostics, and management. , 2013, Circulation.
[29] P. Heidenreich,et al. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. , 2013, Journal of the American College of Cardiology.
[30] P. Sanders,et al. Antitachycardia pacing for very fast ventricular tachycardia and low-energy shock for ventricular arrhythmias in patients with implantable defibrillators. , 2013, The American journal of cardiology.
[31] Mark Kremers,et al. Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator , 2013, Circulation.
[32] M. A. Arias,et al. The reverse mode switch algorithm: how well does it work? , 2013, Heart rhythm.
[33] Lluís Mont,et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.
[34] T. Pereira,et al. Inappropriate Shocks in Patients with ICDs: Single Chamber versus Dual Chamber , 2013, Arquivos brasileiros de cardiologia.
[35] Mitchell W Krucoff,et al. The efficacy and safety of cardiac resynchronization therapy combined with implantable cardioverter defibrillator for heart failure: a meta-analysis of 5674 patients. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[36] A. Proclemer,et al. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. , 2013, JAMA.
[37] K. Smits,et al. Impact of defibrillation testing on predicted ICD shock efficacy: implications for clinical practice. , 2013, Heart rhythm.
[38] C. Sticherling,et al. Role of Defibrillation Threshold Testing in the Contemporary Defibrillator Patient Population , 2013, Journal of cardiovascular electrophysiology.
[39] R. Verheggen,et al. Incidence and predictors of phantom shocks in implantable cardioverter defibrillator recipients , 2013, Netherlands Heart Journal.
[40] John Rumsfeld,et al. The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. , 2013, Heart rhythm.
[41] E. Kanal,et al. ACR guidance document on MR safe practices: 2013 , 2013, Journal of magnetic resonance imaging : JMRI.
[42] Dominique Lacroix,et al. A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial , 2012, European heart journal.
[43] Wojciech Zareba,et al. Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.
[44] J. Healey,et al. A Randomized‐Controlled Pilot Study Comparing ICD Implantation with and Without Intraoperative Defibrillation Testing in Patients with Heart Failure and Severe Left Ventricular Dysfunction: A Substudy of the RAFT Trial , 2012, Journal of cardiovascular electrophysiology.
[45] M. Stiles,et al. Recommendations for the programming of implantable cardioverter-defibrillators in New Zealand. , 2012, Heart, lung & circulation.
[46] David O. Martin,et al. Atrial Support Pacing in Heart Failure: Results from the Multicenter PEGASUS CRT Trial , 2012, Journal of cardiovascular electrophysiology.
[47] John Gorcsan,et al. Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. , 2012, Heart rhythm.
[48] S. González-Enríquez,et al. Single-chamber ICD, single-zone therapy in primary and secondary prevention patients: the simpler the better? , 2012, Journal of Interventional Cardiac Electrophysiology.
[49] J. Sellal,et al. Safety and efficacy of programming a high number of antitachycardia pacing attempts for fast ventricular tachycardia: a prospective study. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[50] H. Morita,et al. Cardiac Dysfunction and Prolonged Hemodynamic Deterioration After Implantable Cardioverter-Defibrillator Shock in Patients With Systolic Heart Failure , 2012, Circulation. Arrhythmia and electrophysiology.
[51] M. Brignole,et al. Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant. , 2012, Journal of the American College of Cardiology.
[52] Luigi Padeletti,et al. A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[53] K. Bailey,et al. Prospective Randomized Trial of Dual Chamber vs. Single Chamber ICDs to Minimize Shocks in Optimally Programmed Devices , 2012 .
[54] A. Russo,et al. HRS/ACCF expert consensus statement on pacemaker device and mode selection. , 2012, Journal of the American College of Cardiology.
[55] S. Asirvatham,et al. Noise, Artifact, and Oversensing Related Inappropriate ICD Shock Evaluation: ALTITUDE NOISE Study , 2012, Pacing and clinical electrophysiology : PACE.
[56] L. Fauchier,et al. Long-term follow-up on high-rate cut-off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunction. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[57] W. Toff,et al. Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[58] J. Rey,et al. Effect of a Pacing Mode Preserving Spontaneous AV Conduction on Ventricular Pacing Burden and Atrial Arrhythmias , 2012, Pacing and clinical electrophysiology : PACE.
[59] M. Gold,et al. Head‐To‐Head Comparison of Arrhythmia Discrimination Performance of Subcutaneous and Transvenous ICD Arrhythmia Detection Algorithms: The START Study , 2012, Journal of cardiovascular electrophysiology.
[60] C. Swerdlow,et al. A fully automatic, implantable cardioverter-defibrillator algorithm to prevent inappropriate detection of ventricular tachycardia or fibrillation due to T-wave oversensing in spontaneous rhythm. , 2012, Heart rhythm.
[61] A. Russo,et al. Arrhythmia rate distribution and tachyarrhythmia therapy in an ICD population: results from the INTRINSIC RV trial. , 2012, Heart rhythm.
[62] Barry J Maron,et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.
[63] N. Uriel,et al. Rate responsive pacing using cardiac resynchronization therapy in patients with chronotropic incompetence and chronic heart failure. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[64] Emily A. Kuhl,et al. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. , 2011, Journal of psychosomatic research.
[65] A. Dhala,et al. Inappropriate Shocks in Patients With Fidelis® Lead Fractures: Impact of Remote Monitoring and the Lead Integrity Algorithm , 2011, Journal of cardiovascular electrophysiology.
[66] P. Heidenreich,et al. Real World Evaluation of Dual‐Zone ICD and CRT‐D Programming Compared to Single‐Zone Programming: The ALTITUDE REDUCES Study , 2011, Journal of cardiovascular electrophysiology.
[67] P. Friedman,et al. Strategies to Reduce ICD Shocks: The Role of Supraventricular Tachycardia–Ventricular Tachycardia Discriminators , 2011 .
[68] P. Heidenreich,et al. Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. , 2011, Heart rhythm.
[69] M. Fleckenstein,et al. Reduction of Right Ventricular Pacing with Advanced Atrioventricular Search Hysteresis: Results of the PREVENT Study , 2011, Pacing and clinical electrophysiology : PACE.
[70] K. Ellenbogen,et al. Preventing overdiagnosis of implantable cardioverter-defibrillator lead fractures using device diagnostics. , 2011, Journal of the American College of Cardiology.
[71] G. Lloyd,et al. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[72] J. Conti,et al. Posttraumatic stress and the implantable cardioverter-defibrillator patient: what the electrophysiologist needs to know. , 2011 .
[73] P. Khairy,et al. Programming ICDs in the Modern Era beyond Out‐of‐the Box Settings , 2011, Pacing and clinical electrophysiology : PACE.
[74] D. Exner,et al. Combining Shock Reduction Strategies to Enhance ICD Therapy: A Role for Computer Modeling , 2011, Journal of cardiovascular electrophysiology.
[75] W. Toff,et al. A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. , 2011, European heart journal.
[76] M. Chauvin,et al. Outcome of patients aged over 75 years who received a pacemaker to treat sinus node dysfunction. , 2011, Archives of cardiovascular diseases.
[77] John L Sapp,et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.
[78] J. Healey,et al. Defibrillation Testing at the Time of ICD Insertion: An Analysis From the Ontario ICD Registry , 2010, Journal of cardiovascular electrophysiology.
[79] A. Massumi,et al. Programming Antitachycardia Pacing for Primary Prevention in Patients With Implantable Cardioverter Defibrillators: Results From the PROVE Trial , 2010, Journal of cardiovascular electrophysiology.
[80] K. Ellenbogen,et al. Atrial pacing or ventricular backup-only pacing in implantable cardioverter-defibrillator patients. , 2010, Heart rhythm.
[81] K. Ellenbogen,et al. Downloadable Software Algorithm Reduces Inappropriate Shocks Caused by Implantable Cardioverter-Defibrillator Lead Fractures: A Prospective Study , 2010, Circulation.
[82] M. Santini,et al. BIVentricular versus right ventricular antitachycardia pacing to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy: the ADVANCE CRT-D Trial. , 2010, American heart journal.
[83] Manish S. Gupta,et al. Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: the Frequent Optimization Study Using the QuickOpt Method (FREEDOM) trial. , 2010, American heart journal.
[84] B. Wilkoff,et al. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. , 2010, Heart rhythm.
[85] J. Healey,et al. Canadian Registry of ICD Implant Testing Procedures (CREDIT): Current Practice, Risks, and Costs of Intraoperative Defibrillation Testing , 2010, Journal of cardiovascular electrophysiology.
[86] M. Santini,et al. Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp DeliVery for pAiNless ICD thErapy (ADVANCE-D) Trial results , 2010, Journal of Interventional Cardiac Electrophysiology.
[87] Paul A. Belk,et al. The Relationship between Pacing Site and Induction or Termination of Sustained Monomorphic Ventricular Tachycardia by Antitachycardia Pacing , 2010, Pacing and clinical electrophysiology : PACE.
[88] D. Slotwiner,et al. Frequent Recurrent Polymorphic Ventricular Tachycardia during Sleep Due to Managed Ventricular Pacing , 2009, Pacing and clinical electrophysiology : PACE.
[89] Wojciech Zareba,et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.
[90] T. Murohara,et al. Difference in percentage of ventricular pacing between two algorithms for minimizing ventricular pacing: results of the IDEAL RVP (Identify the Best Algorithm for Reducing Unnecessary Right Ventricular Pacing) study , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[91] Jesús Requena-Carrión,et al. Sensitivity and Spatial Resolution of Transvenous Leads in Implantable Cardioverter Defibrillator , 2009, IEEE Transactions on Biomedical Engineering.
[92] G. Boriani,et al. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection wind , 2009, European heart journal.
[93] Jeroen J. Bax,et al. Echocardiography and noninvasive imaging in cardiac resynchronization therapy: results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective. , 2009, Journal of the American College of Cardiology.
[94] P. Pascale,et al. Pacemaker Syndrome During Managed Ventricular Pacing Mode: What is the Mechanism? , 2009, Journal of cardiovascular electrophysiology.
[95] B. Zrenner,et al. Defibrillation Threshold Testing: Tradition or Necessity? , 2009, Pacing and clinical electrophysiology : PACE.
[96] M. Scherillo,et al. A Randomized Study to Compare Ramp Versus Burst Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: The PITAGORA ICD Trial , 2009, Circulation. Arrhythmia and electrophysiology.
[97] P. Kudenchuk,et al. The DAVID (Dual Chamber and VVI Implantable Defibrillator) II trial. , 2009, Journal of the American College of Cardiology.
[98] Wilfried Mullens,et al. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. , 2009, Journal of the American College of Cardiology.
[99] Alfons F. Sinnaeve,et al. Sensing and Detection , 2009 .
[100] S. A. Christman,et al. Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? , 2009, Journal of the American College of Cardiology.
[101] K. Ellenbogen,et al. Downloadable Algorithm to Reduce Inappropriate Shocks Caused by Fractures of Implantable Cardioverter-Defibrillator Leads , 2008, Circulation.
[102] Paul A. Belk,et al. Severe Atrioventricular Decoupling, Uncoupling, and Ventriculoatrial Coupling During Enhanced Atrial Pacing: Incidence, Mechanisms, and Implications for Minimizing Right Ventricular Pacing in ICD Patients , 2008, Journal of cardiovascular electrophysiology.
[103] D. Mark,et al. Prognostic importance of defibrillator shocks in patients with heart failure. , 2008, The New England journal of medicine.
[104] C. Işıkay,et al. Defibrillation testing and early neurologic outcome. , 2008, International heart journal.
[105] A. Thiagalingam,et al. Discriminatory Therapy for Very Fast Ventricular Tachycardia in Patients with Implantable Cardioverter Defibrillators , 2008, Pacing and clinical electrophysiology : PACE.
[106] D. Mark,et al. No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). , 2008, Journal of the American College of Cardiology.
[107] Stephen L Moore,et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. , 2008, Journal of the American College of Cardiology.
[108] S. Sears,et al. State‐of‐the‐art: anxiety management in patients with implantable cardioverter defibrillators , 2008 .
[109] C. Wolpert,et al. Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[110] Wojciech Zareba,et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. , 2008, Journal of the American College of Cardiology.
[111] J. Healey,et al. Complications associated with defibrillation threshold testing: the Canadian experience. , 2008, Heart rhythm.
[112] C. Israel,et al. Comparison of Two Strategies to Reduce Ventricular Pacing in Pacemaker Patients , 2008, Pacing and clinical electrophysiology : PACE.
[113] M. Mollerus,et al. Myocardial stunning following defibrillation threshold testing , 2007, Journal of Interventional Cardiac Electrophysiology.
[114] G. Lamas,et al. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. , 2007, The New England journal of medicine.
[115] G. Lamas,et al. Impact of rate-modulated pacing on quality of life and exercise capacity--evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT). , 2007, Heart rhythm.
[116] Paul A. Belk,et al. Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias: a possible mechanism of proarrhythmia? , 2007, Journal of the American College of Cardiology.
[117] G. O'hara,et al. Optimizing implantable cardioverter-defibrillator treatment of rapid ventricular tachycardia: antitachycardia pacing therapy during charging. , 2007, Heart rhythm.
[118] A. Russo,et al. The Dilemma of ICD Implant Testing , 2007, Pacing and clinical electrophysiology : PACE.
[119] Angelo Auricchio,et al. Clinical Cardiac Pacing, Defibrillation and Resynchronization Therapy , 2007 .
[120] J. Day,et al. Is Dual-Chamber Programming Inferior to Single-Chamber Programming in an Implantable Cardioverter-Defibrillator?: Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) Study , 2006, Circulation.
[121] A. Skanes,et al. Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation. , 2006, American heart journal.
[122] I. V. Van Gelder,et al. Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patients. , 2006, Heart rhythm.
[123] Arjun D. Sharma,et al. Improving SVT Discrimination in Single‐Chamber ICDs: A New Electrogram Morphology‐Based Algorithm , 2006, Journal of cardiovascular electrophysiology.
[124] Dick M. Goedhart,et al. Evaluation of morphology discrimination for ventricular tachycardia diagnosis in implantable cardioverter-defibrillators. , 2006, Heart rhythm.
[125] Catherine Klersy,et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. , 2006, Journal of the American College of Cardiology.
[126] Zengri J. Wang,et al. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. , 2006, Journal of the American College of Cardiology.
[127] L. Goldman,et al. Cardiovascular Outcomes With Atrial-Based Pacing Compared With Ventricular Pacing: Meta-Analysis of Randomized Trials, Using Individual Patient Data , 2006, Circulation.
[128] C. Israel,et al. Reducing Unnecessary Right Ventricular Pacing with the Managed Ventricular Pacing Mode in Patients with Sinus Node Disease and AV Block , 2006, Pacing and clinical electrophysiology : PACE.
[129] W. Bamlet,et al. Dual-Chamber Versus Single-Chamber Detection Enhancements for Implantable Defibrillator Rhythm Diagnosis: The Detect Supraventricular Tachycardia Study , 2006, Circulation.
[130] K. Ellenbogen,et al. Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure. , 2006, Heart rhythm.
[131] L. Di Biase,et al. Is a Dual‐Sensor Pacemaker Appropriate in Patients with Sino‐Atrial Disease? Results from the DUSISLOG Study , 2006, Pacing and clinical electrophysiology : PACE.
[132] Arjun D. Sharma,et al. Percent right ventricular pacing predicts outcomes in the DAVID trial. , 2005, Heart rhythm.
[133] A. Camm,et al. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. , 2005, The New England journal of medicine.
[134] B. Wilkoff,et al. Optimal Combination of Discriminators for Differentiating Ventricular from Supraventricular Tachycardia by Dual‐Chamber Defibrillators , 2005, Journal of cardiovascular electrophysiology.
[135] M. Sweeney,et al. Appropriate and Inappropriate Ventricular Therapies, Quality of Life, and Mortality Among Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients: Results From the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) Trial , 2005, Circulation.
[136] A. Russo,et al. Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion? , 2005, Heart rhythm.
[137] Paul J. Wang,et al. The Clinical Implications of Cumulative Right Ventricular Pacing in the Multicenter Automatic Defibrillator Trial II , 2005, Journal of cardiovascular electrophysiology.
[138] S. Vonhof,et al. Inappropriate therapy and fatal proarrhythmia by an implantable cardioverter-defibrillator. , 2005, Heart rhythm.
[139] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[140] Dick M. Goedhart,et al. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms. , 2004, Journal of the American College of Cardiology.
[141] S. Kimber,et al. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator. , 2004, Heart rhythm.
[142] Michael O. Sweeney,et al. Prospective Randomized Multicenter Trial of Empirical Antitachycardia Pacing Versus Shocks for Spontaneous Rapid Ventricular Tachycardia in Patients With Implantable Cardioverter-Defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) Trial Results , 2004, Circulation.
[143] S. Hohnloser,et al. The 1+1 Trial: A Prospective Trial of a Dual- Versus a Single-Chamber Implantable Defibrillator in Patients With Slow Ventricular Tachycardias , 2004, Circulation.
[144] Simonetta Dell'Orto,et al. Sensors for rate responsive pacing , 2004, Indian pacing and electrophysiology journal.
[145] Hugh Calkins,et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. , 2004, The New England journal of medicine.
[146] J. Kron. Clinical significance of device-related complications in clinical trials and implications for future trials: insights from the Antiarrhytmics Versus Implantable Defibrillators (AVID) trial. , 2003, Cardiac electrophysiology review.
[147] D. Wyse,et al. Analysis of Implantable Cardioverter Defibrillator Therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial , 2003, Journal of cardiovascular electrophysiology.
[148] G. Lamas,et al. Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction , 2003, Circulation.
[149] K. Nanthakumar,et al. Is Inappropriate Implantable Defibrillator Shock Therapy Predictable? , 2003, Journal of Interventional Cardiac Electrophysiology.
[150] R. Stadler,et al. An Adaptive Interval‐Based Algorithm for Withholding ICD Therapy During Sinus Tachycardia , 2003, Pacing and clinical electrophysiology : PACE.
[151] David O. Martin,et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. , 2002, JAMA.
[152] M. Jensen-Urstad,et al. Transient proarrhythmic state following atrioventricular junction radiofrequency ablation: pathophysiologic mechanisms and recommendations for management. , 2002, The American journal of medicine.
[153] L. Goldman,et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. , 2002, The New England journal of medicine.
[154] M. Sweeney. Novel Cause of Spurious Mode Switching in Dual‐Chamber Pacemakers: Atrioventricular Desynchronization Arrhythmia , 2002, Journal of cardiovascular electrophysiology.
[155] Walter H Olson,et al. Discrimination of Ventricular Tachycardia from Supraventricular Tachycardia by a Downloaded Wavelet‐Transform Morphology Algorithm: A Paradigm for Development of Implantable Cardioverter Defibrillator Detection Algorithms , 2002, Journal of cardiovascular electrophysiology.
[156] M. Gold,et al. Efficacy and Temporal Stability of Reduced Safety Margins for Ventricular Defibrillation: Primary Results From the Low Energy Safety Study (LESS) , 2002, Circulation.
[157] C. Visser,et al. The Effect of Rate Responsive Pacing in Patients with Angina Pectoris on the Extent of Ischemia on 201‐Thallium Exercise Scintigraphy , 2002, Pacing and clinical electrophysiology : PACE.
[158] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .
[159] Judy Powell,et al. Quality of Life in the Antiarrhythmics Versus Implantable Defibrillators Trial: Impact of Therapy and Influence of Adverse Symptoms and Defibrillator Shocks , 2002, Circulation.
[160] R. Lazzara,et al. Analysis of Troponin I Levels After Spontaneous Implantable Cardioverter Defibrillator Shocks , 2002, Journal of cardiovascular electrophysiology.
[161] G. Breithardt,et al. Effect of Ventricular Fibrillation Duration on the Defibrillation Threshold in Humans , 2002, Pacing and clinical electrophysiology : PACE.
[162] Michael O. Sweeney,et al. Shock Reduction Using Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardia in Patients With Coronary Artery Disease , 2001, Circulation.
[163] C. Swerdlow. Implantation of Cardioverter Defibrillators Without Induction of Ventricular Fibrillation , 2001, Circulation.
[164] H. Baum,et al. Effects of implantable cardioverter defibrillator implantation and shock application on biochemical markers of myocardial damage. , 2001, Clinical chemistry.
[165] K. Ellenbogen,et al. Critical Analysis of Dual-Chamber Implantable Cardioverter-Defibrillator Arrhythmia Detection: Results and Technical Considerations , 2001, Circulation.
[166] S. Connolly,et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. , 2000, European heart journal.
[167] M Gent,et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes , 2000 .
[168] C. Lau,et al. Developments in sensor-driven pacing. , 2000, Cardiology clinics.
[169] K. Lee,et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.
[170] B. Waldecker,et al. Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators. , 1999, Journal of the American College of Cardiology.
[171] A. Camm,et al. Examining the psychosocial impact of implantable cardioverter defibrillators: A literature review , 1999, Clinical cardiology.
[172] G. Breithardt,et al. Efficacy and Safety of the Initial Use of Stability and Onset Criteria in Implantable Cardioverter Defibrillators , 1999, Journal of cardiovascular electrophysiology.
[173] Wojciech Zareba,et al. Multicenter Automatic Defibrillator Implantation Trial II (MADIT II): Design and Clinical Protocol , 1999 .
[174] M. Rosenqvist,et al. Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators. , 1998, Circulation.
[175] J. Diephuis,et al. Changes in Cerebral Oxygen Uptake and Cerebral Electrical Activity During Defibrillation Threshold Testing , 1998, Anesthesia and analgesia.
[176] L. Goldman,et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. , 1998, Pacing and clinical electrophysiology : PACE.
[177] J. Brugada,et al. Enhanced Detection Criteria in Implantable Defibrillators , 1998, Journal of cardiovascular electrophysiology.
[178] M. Keller,et al. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.
[179] J. Brugada,et al. Ventricular Fibrillation and Sudden Death After Radiofrequency Catheter Ablation of the Atrioventricular Junction , 1997, Pacing and clinical electrophysiology : PACE.
[180] R. Peters,et al. Complications Associated with Pectoral Implantation of Cardioverter Defibrillators , 1997, Pacing and clinical electrophysiology : PACE.
[181] M. Gold,et al. Effects of an active pectoral-pulse generator shell on defibrillation efficacy with a transvenous lead system. , 1996, The American journal of cardiology.
[182] R. Yee,et al. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators. , 1996, Journal of the American College of Cardiology.
[183] G. Wieneke,et al. The impact of repeated short episodes of circulatory arrest on cerebral function. Reassuring electroencephalographic (EEG) findings during defibrillation threshold testing at defibrillator implantation. , 1996, Electroencephalography and clinical neurophysiology.
[184] A. Tajik,et al. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy. Acute Doppler echocardiographic and catheterization hemodynamic study. , 1996, Journal of the American College of Cardiology.
[185] S. Pinski,et al. The proarrhythmic potential of implantable cardioverter-defibrillators. , 1995, Circulation.
[186] M. Schlepper,et al. Programmable VT Detection Enhancements in Implantable Cardioverter Defibrillator Therapy , 1995, Pacing and clinical electrophysiology : PACE.
[187] E. Gang,et al. Underdetection of ventricular tachycardia by algorithms to enhance specificity in a tiered-therapy cardioverter-defibrillator. , 1994, Journal of the American College of Cardiology.
[188] A. Natale,et al. Preliminary experience with a hybrid nonthoracotomy defibrillating system that includes a biphasic device: comparison with a standard monophasic device using the same lead system. , 1994, Journal of the American College of Cardiology.
[189] P. S. Chen,et al. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. , 1994, Journal of the American College of Cardiology.
[190] H. Edmonds,et al. Changes in cerebral perfusion during third-generation implantable cardioverter defibrillator testing. , 1994, American heart journal.
[191] M. Schlepper,et al. Effect of Biphasic Waveform Pulse on Endocardial Defibrillation Efficacy in Humans , 1994, Pacing and clinical electrophysiology : PACE.
[192] B. Lüderitz,et al. Patient Acceptance of the Implantable Cardioverter Defibrillator in Ventricular Tachyarrhythmias , 1993, Pacing and clinical electrophysiology : PACE.
[193] F. Marchlinski,et al. Shock Occurrence and Survival in 241 Patients With Implantable Cardioverter‐ Defibrillator Therapy , 1993, Circulation.
[194] J. Fisher,et al. Initial Experience with Transvenous Implantable Cardioverter Defibrillator Lead Systems: Operative Morbidity and Mortality , 1993, Pacing and clinical electrophysiology : PACE.
[195] F. Marchlinski,et al. Electrocardiographically Documented Unnecessary, Spontaneous Shocks in 241 Patients With Implantable Cardioverter Defibrillators , 1992, Pacing and clinical electrophysiology : PACE.
[196] K. Ellenbogen,et al. Measurement of ventricular electrogram amplitude during intraoperative induction of ventricular tachyarrhythmias. , 1992, The American journal of cardiology.
[197] J. Fisher,et al. Clinical Evaluation of the Safety of Repetitive Intraoperative Defibrillation Threshold Testing , 1992, Pacing and clinical electrophysiology : PACE.
[198] H. Müderrisoğlu,et al. Quality of Life in Patients with Rate Responsive Pacemakers: A Randomized, Cross‐Over Study , 1991, Pacing and clinical electrophysiology : PACE.
[199] N Sulke,et al. A randomized double-blind crossover comparison of four rate-responsive pacing modes. , 1991, Journal of the American College of Cardiology.
[200] A. Camm,et al. Symptomatology and quality of life in patients with rate‐responsive pacemakers: A double‐blind, randomized, crossover study , 1989, Clinical cardiology.
[201] P. Brugada,et al. Pacemaker Syndrome with AAI Rate Variable Pacing: Importance of Atrioventricular Conduction Properties, Medication, and Pacemaker Programmability , 1988, Pacing and clinical electrophysiology : PACE.
[202] V L Gott,et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. , 1980, The New England journal of medicine.
[203] B. Lown,et al. Implanted Standby Defibrillators , 1972, Circulation.
[204] Enneth,et al. QUALITY OF LIFE AND CLINICAL OUTCOMES IN ELDERLY PATIENTS TREATED WITH VENTRICULAR PACING AS COMPARED WITH DUAL-CHAMBER PACING , 2017 .
[205] J. Nielsen,et al. ESC Guidelines on cardiac pacing and cardiac resynchronization therapy , 2014 .
[206] J. Makaryus,et al. Inappropriate Implant able Cardioverter Defibrillator Shocks , 2014 .
[207] A. Meta-analysis,et al. The Impact of Prolonged ICD Arrhythmia Detection , 2014 .
[208] Jeffrey L. Anderson,et al. The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.
[209] A. Proclemer,et al. Efficacy of Long Detection Interval ICD Settings in Secondary Prevention Population: Data from the Advance III Trial , 2014 .
[210] B. Wilkoff,et al. The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients. , 2012, Heart rhythm.
[211] J. Sturdivant. Left Ventricular Versus Simultaneous Biventricular Pacing in Patients With Heart Failure and a QRS Complex ≥120 Milliseconds , 2012 .
[212] K. Ellenbogen,et al. Advances in Arrhythmia and Electrophysiology Minimizing Inappropriate or “Unnecessary” Implantable Cardioverter-Defibrillator Shocks Appropriate Programming , 2011 .
[213] M. Gold,et al. Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchron , 2010, Circulation.
[214] M. Cheitlin. Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events , 2010 .
[215] L. S. Mathias,et al. Impact of induced cardiac arrest on cognitive function after implantation of a cardioverter-defibrillator. , 2009, Revista brasileira de anestesiologia.
[216] D. Desilvey. Minimizing ventricular pacing to reduce atrial fibrillation in sinus node disease. , 2008, The American journal of geriatric cardiology.
[217] P. Friedman,et al. Advanced ICD troubleshooting: Part I. , 2005, Pacing and clinical electrophysiology : PACE.
[218] Alain Ripart,et al. Arrhythmia detection by dual-chamber implantable cardioverter defibrillators. A review of current algorithms. , 2004, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[219] J. W. Harthorne,et al. Effects of physiologic pacing versus ventricular pacing. , 2000, The New England journal of medicine.
[220] N Engl,et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. , 1997, Circulation.
[221] J. Oss,et al. IMPROVED SURVIVAL WITH AN IMPLANTED DEFIBRILLATOR IN PATIENTS WITH CORONARY DISEASE AT HIGH RISK FOR VENTRICULAR ARRHYTHMIA , 1996 .